Peptide degradation FAQ

Discard it—cloudiness indicates aggregation or microbial contamination, either of which renders the solution unusable. Aggregated peptides are biologically inactive and cannot be restored to monomeric form by filtration, dilution, or re-dissolution. If bacteriostatic water was used and sterile technique maintained, cloudiness more likely reflects aggregation than infection, but the result is the same: the peptides are no longer in their functional form. This scenario most commonly occurs with peptides stored at concentrations above 5 mg/mL or those containing long hydrophobic stretches. For future preparations, reconstitute at lower concentration, aliquot into smaller volumes immediately, and store aliquots frozen rather than refrigerated for any timeline beyond two weeks.

Use it for preliminary work but not for final data collection—two freeze-thaw cycles cause measurable but not necessarily total activity loss. Ice crystal formation during freezing mechanically disrupts tertiary structure, and while some peptides refold correctly upon thawing, others do not. The degree of damage depends on sequence: small linear peptides (<10 amino acids) tolerate freeze-thaw better than large peptides with complex disulfide bonding. For compounds like Tesamorelin or Hexarelin, which rely on specific conformations for receptor binding, two cycles may reduce potency by 15–30%. If no fresh aliquots remain, use the freeze-thawed sample for method development or optimization runs, then repeat key experiments with a new vial aliquoted properly from the start.

Use an insulated medical cooler with ice packs and verify temperature remains below 8°C throughout transport—temperature excursions above this threshold trigger accelerated degradation that continues even after re-cooling. Insulin travel cases designed for diabetes patients work well for peptide transport because they maintain 2–8°C for 12–48 hours depending on ambient temperature and model. Avoid direct contact between ice packs and peptide vials (use a barrier layer) to prevent localized freezing. For research involving transport of reconstituted Tirzepatide, Retatrutide, or other GLP-1 analogs, temperature-logging stickers (available from laboratory suppliers) provide verification that cold chain was maintained—critical if transported samples will be used for quantitative assays where small potency losses matter.

Store it at −20°C and use it—lyophilized peptides tolerate short-term room temperature exposure far better than reconstituted solutions. The absence of water dramatically slows hydrolysis and eliminates aggregation risk, making lyophilized peptides stable at ambient temperature for days to weeks depending on sequence. Peptides with multiple Met or Cys residues may show trace oxidation from prolonged air exposure, but for most sequences the primary concern is moisture absorption rather than chemical degradation. If the vial seal remained intact and the powder appears dry (not clumped or discolored), bioactivity loss is likely minimal. For critical experiments, consider running a dose-response comparison against a freshly received vial to verify potency if degradation is suspected.

Discard it. Lyophilised Follistatin-344 stored at room temperature (20–25°C) for 8+ hours has already undergone thermal stress sufficient to initiate aggregation, even if the powder still looks white and intact. The conformational damage isn't reversible, and using degraded peptide introduces uncontrolled variables that compromise research validity. There's no reliable way to test potency retention at the bench level. Spectroscopic analysis would be required, and by the time you've arranged that, the cost exceeds simply replacing the vial.

Test the pH immediately. If pH is between 6.5 and 7.5 and the cloudiness is faint (opalescent rather than opaque), it may still be usable for non-critical applications. But don't assume full potency. Opalescence can result from minor aggregation or residual particulates in the bacteriostatic water itself. If pH is outside range or the solution is visibly turbid with floating particles, discard it. Cloudiness that develops over hours after reconstitution (rather than being present immediately) almost always indicates bacterial contamination or ongoing aggregation. Both render the peptide unusable.

Assume the vacuum seal was compromised during shipping or storage. Even if the lyophilised powder looks normal, oxygen and moisture ingress have accelerated oxidative degradation. The peptide may retain partial activity, but you won't know how much potency was lost without third-party testing. For critical research protocols where reproducibility matters, replace the vial. For preliminary or tolerance studies, you can proceed with the understanding that results may not be replicable with fresh peptide. But document the seal failure in your protocol notes.

Request a replacement immediately if the peptide was shipped at ambient temperature. Lyophilised PE-22-28 can tolerate short-term exposure (24–48 hours) to temperatures up to 25°C without catastrophic degradation, but you have no way to verify how long it was exposed or what the peak temperature reached. Most reputable suppliers like Real Peptides use cold chain logistics with temperature monitoring. If yours didn't, the supplier cut a corner that invalidates quality assurance.

Discard it immediately. Even faint yellowing indicates methionine oxidation has progressed beyond early stages, meaning bioactivity is already compromised by 20–40%. Oxidation is cumulative and irreversible. The yellow tone you see today will be brown within 2–4 weeks, and potency degrades faster than color intensifies. No method exists to reverse peptide oxidation once it occurs.

Do not use it. Twelve hours at 20–25°C causes approximately 30–50% bioactivity loss in reconstituted peptide solutions, and microbial contamination risk becomes significant after 6 hours without refrigeration. The solution may appear clear and normal, but oxidative and hydrolytic degradation proceed rapidly at ambient temperature. Label the vial as compromised and dispose of it properly.

If the particles don't dissolve after 60 seconds of gentle swirling, it's contamination or aggregation, not undissolved peptide. True undissolved peptide sinks and dissolves with agitation; floating particles indicate protein aggregates from oxidation or microbial contaminants introduced during reconstitution. Do not attempt to filter the solution. Discard it.

Aliquot the reconstituted peptide into single-use vials and store at −20°C or −80°C. Freezing halts oxidation, aggregation, and hydrolysis by reducing molecular motion to near-zero. Thaw one aliquot at a time by placing it in a 4°C refrigerator for 30–60 minutes—never microwave or use warm water. A peptide stored frozen in aliquots retains 85–95% potency for 6–12 months, compared to 50–60% if stored as a single vial at 4°C.

Run a side-by-side comparison using a freshly reconstituted vial. If your assay measures receptor binding or cellular response, compare stored peptide performance against a known-good control. A >20% reduction suggests meaningful degradation. For research-critical applications, consider HPLC analysis to quantify intact peptide versus degradation products. Researchers who test peptide integrity before starting protocols save more time and funding than those who troubleshoot failed experiments afterward.

Do not use it. Cloudiness or particulate formation indicates advanced aggregation—hydrophobic segments have collapsed into insoluble complexes that no longer bind target receptors. Aggregation is irreversible. Discard the sample and reconstitute fresh. To prevent recurrence: store at 4°C, use Tris-HCl buffer instead of water, and keep peptide concentration below 2 mg/mL if your protocol allows.

Refrigerate it immediately and use it within 48 hours. Every hour at 25°C accelerates degradation by approximately 3× compared to 4°C—an 8-hour exposure degrades the peptide equivalent to 24 hours refrigerated. For oxidation-sensitive peptides like SLU PP 332 Peptide, this could mean 15–20% potency loss. If the peptide is critical and you have backup vials, discard the compromised sample and reconstitute fresh.